| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.03B | 28.96B | 29.52B | 30.48B | 28.28B | 24.53B |
| Gross Profit | 8.42B | 8.43B | 8.42B | 8.65B | 7.43B | 6.29B |
| EBITDA | 2.33B | 2.33B | 2.52B | 2.87B | 2.17B | 1.32B |
| Net Income | 1.54B | 1.40B | 1.59B | 1.86B | 1.62B | 735.00M |
Balance Sheet | ||||||
| Total Assets | 28.32B | 28.65B | 29.89B | 30.92B | 28.85B | 26.24B |
| Cash, Cash Equivalents and Short-Term Investments | 9.24B | 7.35B | 9.65B | 9.58B | 7.48B | 6.50B |
| Total Debt | 1.19B | 665.00M | 854.00M | 837.00M | 792.00M | 999.00M |
| Total Liabilities | 7.91B | 7.75B | 8.92B | 10.73B | 10.41B | 9.10B |
| Stockholders Equity | 20.41B | 20.90B | 20.97B | 20.19B | 18.44B | 17.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -405.00M | 858.00M | 2.40B | 1.07B | 1.08B |
| Operating Cash Flow | 0.00 | 963.00M | 1.82B | 2.66B | 1.17B | 1.29B |
| Investing Cash Flow | 0.00 | -1.37B | -950.00M | -49.00M | 327.00M | -315.00M |
| Financing Cash Flow | 0.00 | -1.88B | -802.00M | -513.00M | -511.00M | -278.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥123.13B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
68 Neutral | ¥5.62B | 7.04 | ― | 4.13% | 2.80% | 4.60% | |
67 Neutral | ¥1.04T | 17.88 | 0.85% | 2.36% | 1.79% | 239.72% | |
67 Neutral | ¥106.11B | 5.91 | 2.57% | 3.57% | -1.80% | 16.84% | |
66 Neutral | ¥11.52B | 9.31 | ― | 3.58% | -1.90% | -3.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥471.36B | -31.80 | 1.44% | 4.80% | 0.40% | 306.91% |